Vigil Neuroscience
About Vigil Neuroscience
Vigil Neuroscience is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. The company aims to address significant unmet medical needs in the field of neurology through its proprietary drug development platform.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | May 22, 2025 | $50.0M | Unknown |
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
Today's Stock Picks $VIGL Vigil Acquired by Sanofi ( $SNY) $600M Acquisition Sanofi acquires Vigil Neuroscience for $8/share, valuing it at $470M, with a CVR of $2/share if its lead drug reaches market. Vigil has raised $353M in five rounds: $50M Series A (2020) $90M Series B https://t.co/FUbDDeIWBk
Similar Startups
Therini Bio
88% matchTherini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegene...
Neurolabs
87% matchNeurolabs is a London-based startup specializing in synthetic computer vision technology. The compan...
CND Life Sciences
86% matchCND Life Sciences is a neurodiagnostics startup focused on advancing the understanding and treatment...
Neuralink
86% matchNeuralink is a neurotechnology company focused on developing implantable brain–machine interfaces (B...